Concepedia

Nadima Uprety

NU

Statistics

Publications

21

Citations

2K

H-Index

20

Active since

2016

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Hospital Israelita Albert Einstein

Universidade de São Paulo

University of Houston

The University of Texas at Austin

Nadima Uprety is an author at The University of Texas MD Anderson Cancer Center specializing in life sciences, immunology, and natural killer cell biology.

ORCID

Publications per year

2016–2025

21

Publications

21

Safety, efficacy and determinants of response of allogeneic CD19-specific CAR-NK cells in CD19+ B cell tumors: a phase 1/2 trial

David Marín, Ye Li, Rafet Başar et al. · Nature Medicine · 2024 · 457 citations · Full text

, , +17

Targeting a cytokine checkpoint enhances the fitness of armored cord blood CAR-NK cells

May Daher, Rafet Başar, Elif Gokdemir et al. · Blood · 2020 · 289 citations · Full text

, , +14

Targeting the αv integrin/TGF-β axis improves natural killer cell function against glioblastoma stem cells

Hila Shaim, Mayra Shanley, Rafet Başar et al. · Journal of Clinical Investigation · 2021 · 252 citations · Full text

, , +17

KIR-based inhibitory CARs overcome CAR-NK cell trogocytosis-mediated fratricide and tumor escape

Ye Li, Rafet Başar, Guohui Wang et al. · Nature Medicine · 2022 · 168 citations · Full text

, , +16

Combining AFM13, a Bispecific CD30/CD16 Antibody, with Cytokine-Activated Blood and Cord Blood–Derived NK Cells Facilitates CAR-like Responses Against CD30+ Malignancies

Lucila Nassif Kerbauy, Nancy D. Marín, Mecit Kaplan et al. · Clinical Cancer Research · 2021 · 151 citations · Full text

, , +17

1–5 of 21